April 18, 2006

My Usual Skepticism On Genetic Research

Scientists think they've identified a strong candidate gene for schizophrenia and are beginning to get an understanding of how it affects the brain. That's fascinating, but it doesn't mean squat for schizophrenics today since it would be a good 20 years until, should it be a valid theory, it turns into a fix. Until then, the state of the art isn't too promising for patients. Haven't we got something more workable and tolerable to offer schizophrenics in the meantime than Zyprexa and Risperdal? Can't we do the equivalent of the CATIE study on how schizophrenics who have gotten better got that way? Josh Nash didn't win that Nobel Prize because of Haldol, after all.

Posted by Philip Dawdy at April 18, 2006 12:03 AM
StumbleUpon Toolbar del.icio.us Digg it reddit
Comments

Seroquel became the new popular antipsychotic, along with Abilify, thus the decline in Zyprexa sales. Coming soon from Solvay, the manufacturer of Lithobid and Luvox is a new antipsychotic that surely will kick the rest down the list of overly prescribed anitpsychotics, once it is available to the docs and they get all of the free samples, pens, notepads and clipboards. Unfortunately, mind altering drugs that leave lives altered sometimes for good and sometimes not, is a big business. Whatever sells gets the attention. In the meantime, it is the human beings, and their lives that are being sold to the highest bidder. I project the newest antipsychotics will be 'deemed promising with less side effects for those suffering with XYZ'.Seems it always starts that way.

http://www.drugdevelopment-technology.com/projects/bifeprunox/

"Bifeprunox mesilate is a novel atypical antipsychotic agent under development by Solvay Pharmaceuticals as a treatment for schizophrenia and potentially conditions such as bipolar disorder."..."Bifeprunox is one four antipsychotic drugs currently in advanced-stage development for treatment of schizophrenia. Analysts believe that of the four, bifeprunox is the most likely to succeed given its promising efficacy and side-effect profile. If approved in 2006 it will join a very crowded market. In the US six atypical agents currently compete for a share of the antipsychotic sector, while in Europe seven atypical agents are now in routine clinical use."

Of course Ive been told that lower stress levels help prevent psychotic episodes. (really? thank you doctor)No fine tuned answers to any of this shit.

Posted by: Stephany at April 19, 2006 08:09 AM

pic1.jpg

Patient Blogs. Sites.
Doctor Blogs. Sites.
Activists. News.
Social Networking. Forums.
Science. Big Pharma. Ethics.
Current Affairs
Seattle Stuff
Smoking. Stuff.

Info
About Furious Seasons
Email
Other Articles
ZYPREXA Documents
Alt ZYPREXA Documents Source
Blakemore-Brown Transcript

 Subscribe in a reader

Recent Entries
Jim Carrey Criticizes Extended Anti-Depressant Use
FDA Orders Suicide Warning For Bipolar, Epilepsy Drugs
Another Seroquel Related Arrest
Minnesota Forced ECT Case Hits NPR Airwaves
Fundraiser Over
Boston Globe Reports Sexual Problems With SSRIs As High As 50 Percent
Winter Fundraiser, So Close It's Not Even Funny
Two Child Physicians Criticize ADHD Meds, The Bipolar Child, Pharma Influence
Michael Phelps: "I Didn't Want To Take Ritalin Anymore"
Winter Fundraiser, Oh So Close
Winter Fundraiser, Inching Closer
10-Year-Old Who Killed Father After Beginning Prozac Gets New Trial
Scientific American Interview: Is Depression Overdiagnosed?
Winter Fundraiser, Day 11
Paxil Documents Online
Recent Comments

Stephany on My Usual Skepticism On Genetic Research

Archives
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
March 2006
February 2006
January 2006
December 2005
November 2005
October 2005
September 2005
Resources
Mental Health America
National Alliance on Mental Illness
Depression and Bipolar Support Alliance
National Institute of Mental Health
McMan Web
Search


Powered by
Movable Type 3.2